VEROVACCiNES GmbH
PrivateLast Round
VC Round
Feb 25, 2025
Total Funding Raised
$7.24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VEROVACCiNES GmbH operates in Healthcare & Life Sciences and is based in Halle (Saale). Its latest recorded funding round was a VC Round in February 2025.
VEROVACCiNES GmbH is a biopharmaceutical company that develops innovative, yeast-based subunit vaccines for animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VEROVACCiNES GmbH Comparables
Compare VEROVACCiNES GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LivingMed Biotech | 85% | |
| The Vaccine Group | 84% | |
| ViroVet | 83% |
For institutional investors. Book with your work email.
VEROVACCiNES GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 25, 2025 | ||||
| Series B | Oct 14, 2021 | ||||
| Seed | Dec 3, 2019 | ||||
| Grant | Dec 3, 2019 | ||||
| Grant | Apr 17, 2018 | ||||
Seed | Dec 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VEROVACCiNES GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gründungsoffensive Biotechnologie (GO-Bio) of the Federal Ministry of Education and Research (BMBF) | Grant |
| High-Tech Gründerfonds | VC Round, Seed |
| Founders | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 4, 2.3x the trailing average.
- Feb 25, 2025
$1.68M round led by High-Tech Gründerfonds.
For institutional investors. Book with your work email.
VEROVACCiNES GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VEROVACCiNES GmbH's valuation, stock price, and market status.
Is VEROVACCiNES GmbH a public or private company?
VEROVACCiNES GmbH is a private company.
What is the current stock price of VEROVACCiNES GmbH?
VEROVACCiNES GmbH is a private company, so its shares have no public market price. Caplight tracks VEROVACCiNES GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VEROVACCiNES GmbH worth (valuation)?
Valuation information for VEROVACCiNES GmbH is not publicly available.
Can I buy VEROVACCiNES GmbH stock?
VEROVACCiNES GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VEROVACCiNES GmbH's last funding round?
VEROVACCiNES GmbH's most recent funding round was VC Round on February 25, 2025.
Who are the main investors in VEROVACCiNES GmbH?
Key investors in VEROVACCiNES GmbH include High-Tech Gründerfonds.
Will VEROVACCiNES GmbH IPO soon?
No public IPO plans have been announced for VEROVACCiNES GmbH.
How can I track VEROVACCiNES GmbH secondary market activity?
Caplight tracks bids, offers, and trades in VEROVACCiNES GmbH's shares on secondary markets.